A new bipartisan, bicameral bill has been reintroduced in Congress that aims to standardize and clarify food date labels to reduce food waste.
The Food Date Labeling Act, brought forth
A subcommittee of the U.S. House Energy and Commerce Committee is set to begin a hearing on infant formula shortages, which are related to recalls of products linked to
Opinion
Some, I am sure, are a bit tired of my ranting about the FSIS doing its job and deeming Salmonella that causes human illness an adulterant in meat.
Fact,
Opinion
Editor’s note: For news about the congressional report, please click here.
The FDA takes exposure to toxic elements in the food supply extremely seriously, especially when it comes
Citing fragmented food safety oversight, which is split up between 15 federal agencies, two lawmakers want Congress to scrap the current system and the ineffective laws that regulate it.
The
The nomination of Mindy Brashears, currently deputy undersecretary for food safety, to be the USDA’s Under Secretary for Food Safety was reported favorably Tuesday out of the Senate Committee
In just the past few months, outbreaks involving romaine lettuce, pre-cut melons and Honey Smacks cereal have reminded us that the work to more effectively prevent foodborne illness is far
President Donald J. Trump wants to consolidate federal food safety under a single agency housed in the U.S. Department of Agriculture.
President Barack Obama also wanted to consolidate food
Some might consider putting Congress on record for or against raw milk as an accomplishment, especially it the vote wasn’t close. An amendment to House Resolution 2 that sought
Editor’s note: U.S. Rep. Rosa DeLauro, D-CT, sent the below letter regarding so-called lab meat and other cell-cultured foods to Gene Dodaro, comptroller general of the United States,
With the ban on USDA’s Food Safety and Inspection Service spending any federal money on equine inspections set to expire Sept. 30, the U.S. House of Representatives and
Editor’s note: This column includes information from an “Advocacy at a Glance” posting by the Alliance for a Stronger FDA and analysis and commentary by Steven Grossman, deputy executive
